Tonix Pharmaceuticals stock halted ahead of FDA approval news
Rocky Brands , Inc. (NASDAQ:RCKY) stock has tumbled to a 52-week low, touching $19.63, marking a steep 13.4% decline in just the past week. According to InvestingPro analysis, the company appears undervalued at current levels, with a current P/B ratio of 0.63. This latest price level reflects a significant downturn from the stock’s performance over the past year, with Rocky Brands experiencing a 31.4% decline. Despite the challenges, the company maintains strong fundamentals with a healthy current ratio of 2.73 and has sustained dividend payments for 13 consecutive years. InvestingPro subscribers can access 8 additional key insights about RCKY’s financial health and growth prospects. The footwear manufacturer, known for its outdoor, work, and military footwear, is navigating through a period of economic uncertainty that has broadly impacted consumer discretionary spending and supply chain dynamics. The company maintains a solid financial foundation with liquid assets exceeding short-term obligations, and analysts project profitability for the current year.
In other recent news, Rocky Brands Inc. reported its fourth-quarter 2024 financial results, showing a mixed performance. The company posted an earnings per share (EPS) of $1.19, missing the forecasted $1.24. However, Rocky Brands exceeded revenue expectations with $128.1 million, surpassing the anticipated $127.16 million. The company also announced a strategic reduction in debt by 25.7% over the past year and approved a new share repurchase program worth $7.5 million. Additionally, tariffs on China-sourced products have increased by 10%, which may affect future profitability. Analysts have noted the company’s proactive steps to mitigate these impacts, such as expanding product lines and reducing manufacturing dependency on China. The company anticipates low single-digit revenue growth for 2025, with gross margins expected to decrease modestly. Despite these challenges, Rocky Brands remains optimistic about its business health as it enters the new year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.